Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1,776–1,800 of 27,380 studies, newest first · page 72 of 1096.

February 2026 9

  1. 2026-02-01

    APP‐mediated intracellular signaling rescues sleep impairment and blood–brain barrier leakage in Alzheimer's disease mouse model

    ✓ Peer-reviewed Risk genes beyond APOE Alzheimer s & Dementia

    Key finding: APP‐mediated signaling plays a key role in regulating sleep, maintaining BBB integrity, and preserving memory in AD.

  2. 2026-02-01

    Social disadvantage outweighs knowledge in dementia risk

    ✓ Peer-reviewed Digital health tools Alzheimer s & Dementia

    Key finding: Lower SES and education were the strongest predictors of increased behavioral risk. +4 more findings

  3. 2026-02-01

    Generative artificial intelligence in dementia care: a scoping review protocol on nursing roles, experiences and ethical perspectives

    ✓ Peer-reviewed Digital health tools BMJ Open

    Key finding: Critical appraisal will not be undertaken, as it is optional in scoping reviews and is not aligned with the primary mapping objectives of this review. +4 more findings

  4. 2026-02-01
  5. 2026-02-01

    Health of Bi+ Dementia Caregivers: Moderation Effects of Minority and Caregiving Stress

    ✓ Peer-reviewed Disparities American Journal of Alzheimer s Disease & Other Dementias®

    Key finding: Bi+ caregivers reported significantly higher minority stress and lower family quality of life but better health than g/l caregivers. +2 more findings

  6. 2026-02-01

    Comparing phenotypic features between Parkinson’s disease dementia and dementia with Lewy bodies

    ✓ Peer-reviewed Getting a diagnosis Journal of Neurology

    Key finding: Patients with PDD showed a more severe phenotype than those with DLB, with higher scores in motor severity, hallucinations, delusions, somnolence, and urinary dysfunction (all p≤0.01). +4 more findings

  7. 2026-02-01

    Sex differences in Alzheimer's disease plasma biomarker levels and clinical utility

    ✓ Peer-reviewed Biomarkers Alzheimer s & Dementia

    Key finding: Among CU participants, men had lower Aβ42 and GFAP, and higher p-tau217/Aβ42. +4 more findings

  8. 2026-02-01

    Plasma p‐tau217 predicts PET‐based pathological staging for precision Alzheimer disease assessment

    ✓ Peer-reviewed Biomarkers Alzheimer s & Dementia

    Key finding: Plasma p-tau217-based biomarkers showed excellent detecting performance for early amyloid (Thal I-II; area under the curve values > 0.96) and intermediate tau (Braak III-IV; area under the curve values > 0.92). +4 more findings

  9. 2026-02-01

January 2026 16

  1. 2026-01-30

    Preventive and Need-Driven Use of Dental Services among Community-Dwelling Older People with Long-Term Care Needs

    ⚠ Preprint — not yet peer-reviewed Health systems and care delivery medRxiv

    Key finding: This study examined patterns of preventive and need-driven dental service use among home-dwelling older adults with LTC needs in Japan and identified the caregiving, functional, and socioeconomic factors associated with these patterns. +3 more findings

    Scored 31 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  2. 2026-01-30

    Lifetime cost-effectiveness of lecanemab for early Alzheimer's disease

    ✓ Peer-reviewed Costs and economics Frontiers in public health

    Key finding: The incremental cost of the lecanemab group compared to the aducanumab group was $30,018.97, with an increase in quality-adjusted life-years (QALYs) of 0.25, resulting in an ICER of $121,678.49 per QALY gained. +4 more findings

  3. 2026-01-30
  4. 2026-01-30

    Crispr/cas9 como alternativa terapêutica para pacientes com doença de Alzheimer: uma revisão integrativa

    ✓ Peer-reviewed Risk genes beyond APOE Revista Neurociências

    Key finding: Además, la corrección de mutaciones como PSEN1 M146L demostró eficacia en la reducción de beta-amiloide y la restauración de funciones celulares. +4 more findings

  5. 2026-01-30

    GABAergic activity and gamma oscillations in Alzheimer’s disease and mild cognitive impairment: Neuropathology and therapeutic neuromodulatory insights from animal and human studies

    ✓ Peer-reviewed Mild cognitive impairment Brain Network Disorders

    Key finding: Disruptions in GABAergic activity and alterations in gamma oscillations are key pathological features of AD associated with amyloid-beta (Aβ) plaques. +2 more findings

  6. 2026-01-30

    A new paradigm for stratified cognitive assessment: fusing serum Raman spectroscopy and ensemble learning

    ✓ Peer-reviewed Getting a diagnosis Alzheimer s Research & Therapy

    Key finding: We developed a serum Raman spectroscopy-based ensemble learning approach for graded cognitive screening. +4 more findings

  7. 2026-01-30

    Causality between Alzheimer disease and delirium: A two-sample Mendelian randomization study and gene colocalization analyses

    ✓ Peer-reviewed Genetics Medicine

    Key finding: The preliminary findings revealed a causal link between AD (21,982 cases and 41,944 controls) and delirium (comprising 1269 cases and 209,487 controls). +3 more findings

  8. 2026-01-30

    Early Behavioral and Cognitive Changes in Patients With Pathologically Confirmed Alzheimer Disease, Lewy Body Dementia, and Mixed Dementia

    ✓ Peer-reviewed Genetics Neurology Open Access

    Key finding: The study included 1,028 participants (mean age at baseline 76.4 years; 47.6% female): 521 with ADP, 96 with LBP, and 411 with mixed AD-LBP. +4 more findings

  9. 2026-01-30
  10. 2026-01-30

    Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIA

    ✓ Peer-reviewed Laboratory science Nature Communications

    Key finding: Here we show, through multi-omic profiling of peripheral blood from three ARIA+ patients and matched controls, that ARIA is associated with coordinated reprogramming of CD8 + T cells. +2 more findings

  11. 2026-01-29

    Proteomic biomarkers of cognitive function, APOE ε4 status, and dementia in Generation Scotland

    ⚠ Preprint — not yet peer-reviewed Biomarkers medRxiv

    Key finding: We observed associations between three cognitive tests (digit symbol, vocabulary and verbal fluency) and a mass spectrometry signal that mapped to selenoprotein P (absolute β range = 0.02 – 0.03, posterior inclusion probability ≥ 0.95). +2 more findings

    Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  12. 2026-01-29

    Elucidation of Molecular Mechanisms of Lipid-Altered Cytotoxicity of TDP-43 Fibrils

    ✓ Peer-reviewed Brain tissue and pathology ACS Chemical Neuroscience

    Key finding: We found that lipid bilayers composed of anionic phosphatidylserine and cardiolipin accelerated TDP-43 aggregation. +2 more findings

  13. 2026-01-29

    Molecular features of human pathological tau distinguish tauopathy-associated dementias

    ✓ Peer-reviewed Digital health tools Cell

    Key finding: In Alzheimer's disease (AD), pathological tau protein shows a progressive accumulation of post-translational modifications (PTMs), reflecting disease severity, progression, and prion-like activity. +4 more findings

  14. 2026-01-29

    Validation of the Danish version of the Carer Experience Scale in family caregivers of people with dementia

    ✓ Peer-reviewed Caregiving Health and Quality of Life Outcomes

    Key finding: The CES effectively distinguished between different levels of caregiver strain. +4 more findings

  15. 2026-01-29

    Neuropsychiatric Symptoms and Caregiver Burden in Dementia: A Longitudinal Dyadic Cohort Study

    ✓ Peer-reviewed Caregiving Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

    Key finding: At baseline, nearly one-third of caregivers reported moderate-to-severe burden (mean ZBI 31.4 ± 15.4), a prevalence that persisted at 6 months. +4 more findings

  16. 2026-01-29

    Postmortem Associations Between Alzheimer Disease Pathology and Plasma pTau217, GFAP, and NfL in AD and AD-Related Dementias

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: One hundred eighty-seven participants with brain autopsy (NPDx1: AD n = 85; other n = 102; mean age: 74.3 years, 38.5% female; interval blood collection-death [mean ± SD]: 2.8 ± 1.6 years) and 67 NC without brain autopsy (mean age: 66.5 years, 71.6% female) were included. pTau217, but not GFAP, levels increased stepwise with increasing Thal phases (β = 0.61; 95% CI [0.24-0.97] to β = 0.91 [0.55-1.27]) and Braak stages (β = 0.59; [0.16-1.01] to β = 0.74 [0.33-1.15]). +4 more findings

Browse the library by subject, with the full score breakdown →